The F-111 Aardvark earned a significant place in aviation history despite early controversy and mixed reviews. Initially facing skepticism due to its dual-role design and political influences ...
Our regular round-up of financings in the biotech sector is headed by rumours of a $150 to $200 million initial public offering (IPO) for Aardvark Therapeutics, an emerging player in the weight ...
The General Dynamics' F-111 Aardvark, also known as "Pig," is one of the most effective military jets ever created. The F-111 was retired by the U.S. Air Force in 1998. The F-111 was created in ...
MEI Pharma inked a deal valued at up to $62 million with Aardvark Therapeutics that sent its stock 30% higher, to $3.55, in after-hours trading. Shares, which ended Friday's regular session flat at $2 ...